Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease
Journal of Vascular Research · 2017 · 54 (1) · 22-32
DOI: 10.1159/000449202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 26.01.2017. Verfasst von Shu-Han Su und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan, ROC. Hauptthemen laut MEDLINE: Neovascularization, Physiologic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background/Aims: Endothelial colony-forming cells (ECFCs) have the potential to be used in regenerative medicine. Dysfunction of ECFCs is correlated with the onset of cardiovascular disorders, especially coronary artery disease (CAD). Binding of vascular endothelial growth factor A (VEGFA) to vascular endothelial growth factor receptor-2 (VEGFR2) triggers cell motility and angiogenesis of ECFCs, which are crucial to vascular repair.
Methods
To identify the miRNA-VEGFR2-dependent regulation of ECFC functions, ECFCs isolated from peripheral blood of disease-free and CAD individuals were subjected to small RNA sequencing for identification of anti-VEGFR2 miRNAs. The angiogenic activities of the miRNAs were determined in both in vitro and in vivo mice models.
Results
Three miRNAs, namely miR-410-3p, miR-497-5p, and miR-2355-5p, were identified to be upregulated in CAD-ECFCs, and VEGFR2 was their common target gene. Knockdown of these miRNAs not only restored the expression of VEGFR2 and increased angiogenic activities of CAD-ECFCs in vitro, but also promoted blood flow recovery in ischemic limbs in vivo. miR-410-3p, miR-497-5p, and miR-2355-5p could serve as potential biomarkers for CAD detection as they are highly expressed in the plasma of CAD patients.
Conclusions
This modulation could help develop new therapeutic modalities for cardiovascular diseases and other vascular dysregulated diseases, especially tumor angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan, ROC.
Zitieren
APA
Su, S. H., Wu, C. H., Chiu, Y. L., Chang, S. J., Lo, H. H., Liao, K. H., Tsai, C. F., Tsai, T. N., Lin, C. H., Cheng, S. M., Cheng, C. C., & Wang, H. W. (2017). Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease. Journal of Vascular Research, 54(1), 22-32. https://doi.org/10.1159/000449202
Vancouver
Su SH, Wu CH, Chiu YL, Chang SJ, Lo HH, Liao KH, et al. Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease. Journal of Vascular Research. 2017;54(1):22-32. doi:10.1159/000449202
BibTeX
@article{Su2017,
author = {Su, Shu-Han and Wu, Chun-Hsien and Chiu, Ya-Lin and Chang, Shing-Jyh and Lo, Hung-Hao and Liao, Ko-Hsun and Tsai, Cheng-Fong and Tsai, Tsung-Neng and Lin, Chi-Hung and Cheng, Shu-Meng and Cheng, Cheng-Chung and Wang, Hsei-Wei},
title = {Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease},
journal = {Journal of Vascular Research},
year = {2017},
volume = {54},
number = {1},
pages = {22--32},
doi = {10.1159/000449202}
}
EUVIMED